|
FR2939909A1
|
|
Video multiplexing and synchronization module for a projection system for relief images
|
|
EP2189453A1
|
|
Rocaglaol derivatives as cardioprotectant agents
|
|
WO2009047330A1
|
|
Use of wnt5a for treating or preventing obesity and atherosclerosis
|
|
WO2009053628A2
|
|
Novel compounds, preparation and uses thereof
|
|
FR2932562A1
|
|
Light projection device structured by means of vcsel and phase diffractive optical components.
|
|
FR2932485A1
|
|
Specific collective release polymer whatever ph
|
|
FR2931946A1
|
|
Aging sensor to be implanted on an integrated microelectronic circuit and integrated circuit thus obtained
|
|
FR2931599A1
|
|
Device for displacing control in translation of an elongated member
|
|
FR2877337A1
|
|
Process for the synthesis of zwitterionic derivatives of benzoquinonemonoimines, compounds obtained and uses thereof
|
|
WO2005030170A2
|
|
Controlled rupture of furtive liposomes
|
|
FR2873444A1
|
|
Piezorheometer measurement cell and corresponding piezorheometer
|
|
FR2873086A1
|
|
Multilayer hood with externally frangible skin with reduced aggressivity in the event of collision with a pieton
|
|
FR2873087A1
|
|
Active safety device comprising a damaging plate covering the windshield of a vehicle in the event of collision with a pieton
|
|
FR2873037A1
|
|
Methods and compositions for the treatment of cancers
|
|
EP1535952A1
|
|
Method for preparing crosslinked polyelectrolyte multilayer films
|
|
FR2862660A1
|
|
System for inducible expression of recombinant proteins in cyanobacteria.
|
|
US2006128695A1
|
|
Cyclic nucleotide phosphodiesterase inhibitors, preparation and uses
|
|
EP1416296A2
|
|
Electronic device for measuring radiation dose
|
|
FR2860233A1
|
|
Compounds promoting the differentiation of oligodendrocyte precursors and modulators of microgial activation, compositions and uses.
|
|
FR2858060A1
|
|
Method and device for measuring a magnetic field in at least one direction
|
